肝疾患の治療戦略となる新しい機序：リゾホスファチジルセリン

• Project/Area Number: 21K15659
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 52010:General internal medicine-related
• Research Institution: The University of Tokyo
• Principal Investigator: 西川 尚子 東京大学, 医学部附属病院, その他 (80814706)
• Project Period (FY): 2021-04-01 – 2023-03-31
• Project Status: Adopted (Fiscal Year 2021)
• Budget Amount: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000); Fiscal Year 2022: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000); Fiscal Year 2021: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)